BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15115621)

  • 1. Prenatal screening and the assessment of risk: the view from the other side.
    Raymer K
    J Obstet Gynaecol Can; 2004 Apr; 26(4):329-32. PubMed ID: 15115621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal screening for and diagnosis of aneuploidy in twin pregnancies.
    Audibert F; Gagnon A; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):754-67. PubMed ID: 21749753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No. 261-Prenatal Screening for Fetal Aneuploidy in Singleton Pregnancies.
    Chitayat D; Langlois S; Wilson RD
    J Obstet Gynaecol Can; 2017 Sep; 39(9):e380-e394. PubMed ID: 28859781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current methods of prenatal screening for Down syndrome and other fetal abnormalities.
    Saller DN; Canick JA
    Clin Obstet Gynecol; 2008 Mar; 51(1):24-36. PubMed ID: 18303497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of non-invasive prenatal screening detection in fetal chromosome aneuploidy].
    Cai AJ; Zhu CF; Xue SW; Cui SY; Qu SZ; Liu N; Kong XD
    Zhonghua Fu Chan Ke Za Zhi; 2017 Nov; 52(11):765-769. PubMed ID: 29179272
    [No Abstract]   [Full Text] [Related]  

  • 7. [What are the real purpose and scope of screening for aneuploidy?].
    Quibel T; Rozenberg P
    Gynecol Obstet Fertil Senol; 2018 Feb; 46(2):124-129. PubMed ID: 29396076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of first-trimester aneuploidy screening in a high-risk population.
    Nadel AS; Likhite ML
    Fetal Diagn Ther; 2009; 26(1):29-34. PubMed ID: 19816027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal Diagnosis Procedures and Techniques to Obtain a Diagnostic Fetal Specimen or Tissue: Maternal and Fetal Risks and Benefits.
    Wilson RD; Gagnon A; Audibert F; Campagnolo C; Carroll J;
    J Obstet Gynaecol Can; 2015 Jul; 37(7):656-668. PubMed ID: 26366824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attitudes towards non-invasive prenatal testing for aneuploidy among US adults of reproductive age.
    Allyse M; Sayres LC; Goodspeed TA; Cho MK
    J Perinatol; 2014 Jun; 34(6):429-34. PubMed ID: 24603453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA sequencing versus standard prenatal aneuploidy screening.
    Bianchi DW; Parker RL; Wentworth J; Madankumar R; Saffer C; Das AF; Craig JA; Chudova DI; Devers PL; Jones KW; Oliver K; Rava RP; Sehnert AJ;
    N Engl J Med; 2014 Feb; 370(9):799-808. PubMed ID: 24571752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal screening: current practice, new developments, ethical challenges.
    de Jong A; Maya I; van Lith JM
    Bioethics; 2015 Jan; 29(1):1-8. PubMed ID: 25521968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of a DNA method, QF-PCR, in the prenatal diagnosis of fetal aneuploidies.
    Langlois S; Duncan A; ;
    J Obstet Gynaecol Can; 2011 Sep; 33(9):955-960. PubMed ID: 21923994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing use of existing prenatal genetic tests: Screening and diagnostic testing for aneuploidy.
    Stoll K; Norton ME
    Semin Perinatol; 2018 Aug; 42(5):296-302. PubMed ID: 30209012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-Free DNA Screening: Complexities and Challenges of Clinical Implementation.
    Grace MR; Hardisty E; Dotters-Katz SK; Vora NL; Kuller JA
    Obstet Gynecol Surv; 2016 Aug; 71(8):477-87. PubMed ID: 27526871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obstetrical complications associated with abnormal maternal serum markers analytes.
    Gagnon A; Wilson RD;
    J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aneuploidy screening by non-invasive prenatal testing in twin pregnancy.
    Fosler L; Winters P; Jones KW; Curnow KJ; Sehnert AJ; Bhatt S; Platt LD
    Ultrasound Obstet Gynecol; 2017 Apr; 49(4):470-477. PubMed ID: 27194226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antenatal screening for aneuploidy.
    Chitty LS
    Curr Opin Obstet Gynecol; 1998 Apr; 10(2):91-6. PubMed ID: 9551302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of non-invasive prenatal testing as a contingent approach on the indications for invasive prenatal diagnosis and prenatal detection rate of Down's syndrome.
    Kou KO; Poon CF; Kwok SL; Chan KY; Tang MH; Kan AS; Leung KY
    Hong Kong Med J; 2016 Jun; 22(3):223-30. PubMed ID: 27149976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive prenatal testing for fetal aneuploidy: clinical assessment and a plea for restraint.
    Norton ME; Rose NC; Benn P
    Obstet Gynecol; 2013 Apr; 121(4):847-850. PubMed ID: 23635685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.